BACKGROUND: Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis. It affects 10-15% of the general population, and is often asymptomatic; leading to under-diagnosis and under-treatment. Atherosclerotic risk factors are often not intensively managed in PAD patients. OBJECTIVE: To summarise the information around the diagnosis and management of PAD in the general practice setting. DISCUSSION: Careful history, clinical examination, and measurement of ankle-brachial index remain the initial means of diagnosing PAD. More detailed anatomic information from duplex imaging, computed tomography angiography and magnetic resonance angiography, is usually unnecessary unless endovascular or surgical intervention is being considered, or if abdominal aortic aneurysm or popliteal aneurysm need to be excluded. Management is focused on lifestyle modification, including smoking cessation and exercise; medical management of atherosclerotic risk factors, including antiplatelet agents, statins, antihypertensive therapy; and agents to improve walking distance, such as cilostazol and ramipril. Endovascular or surgical interventions are usually considered for lifestyle limiting intermittent claudication not responding to conservative therapies, and for critical limb ischaemia.
BACKGROUND:Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis. It affects 10-15% of the general population, and is often asymptomatic; leading to under-diagnosis and under-treatment. Atherosclerotic risk factors are often not intensively managed in PAD patients. OBJECTIVE: To summarise the information around the diagnosis and management of PAD in the general practice setting. DISCUSSION: Careful history, clinical examination, and measurement of ankle-brachial index remain the initial means of diagnosing PAD. More detailed anatomic information from duplex imaging, computed tomography angiography and magnetic resonance angiography, is usually unnecessary unless endovascular or surgical intervention is being considered, or if abdominal aortic aneurysm or popliteal aneurysm need to be excluded. Management is focused on lifestyle modification, including smoking cessation and exercise; medical management of atherosclerotic risk factors, including antiplatelet agents, statins, antihypertensive therapy; and agents to improve walking distance, such as cilostazol and ramipril. Endovascular or surgical interventions are usually considered for lifestyle limiting intermittent claudication not responding to conservative therapies, and for critical limb ischaemia.
Authors: Sybil Yeung; Diana Perriman; Madhur Chhabra; Christine Phillips; Anne Parkinson; Nicholas Glasgow; Kirsty A Douglas; Darlene Cox; Paul Smith; Jane Desborough Journal: BMJ Open Date: 2022-05-30 Impact factor: 3.006
Authors: Amy E Harwood; Sean Pymer; Lee Ingle; Patrick Doherty; Ian C Chetter; Belinda Parmenter; Christopher D Askew; Gary A Tew Journal: BMJ Open Sport Exerc Med Date: 2020-11-05
Authors: Diana Thomas Manapurathe; Smriti Murali Krishna; Brittany Dewdney; Joseph Vaughan Moxon; Erik Biros; Jonathan Golledge Journal: PLoS One Date: 2017-06-02 Impact factor: 3.240
Authors: Jocelyne Mulangala; Emma J Akers; Emma L Solly; Panashe M Bamhare; Laura A Wilsdon; Nathan K P Wong; Joanne T M Tan; Christina A Bursill; Stephen J Nicholls; Belinda A Di Bartolo Journal: Int J Mol Sci Date: 2022-03-20 Impact factor: 5.923